U.S. faces pandemic crossroads with Covid deaths still too high and new omicron variants emerging, Fauci says

U.S. faces pandemic crossroads with Covid deaths still too high and new omicron variants emerging, Fauci says


Dr. Anthony Fauci, White House Chief Medical Advisor and Director of the NIAID, responds to questions from Sen. Rand Paul (R-KY) at a Senate Health, Education, Labor, and Pensions Committee hearing on Capitol Hill on January 11, 2022 in Washington, D.C.

Greg Nash | Pool | Getty Images

White House chief medical advisor Dr. Anthony Fauci on Thursday said the U.S. is at a crossroads in the Covid-19 pandemic as new omicron subvariants are gaining ground across the country.

Fauci, in a radio interview Thursday, said the pandemic has clearly eased since last winter but deaths, which average more than 2,600 per week, remain far too high. At the same time, the new omicron variants are knocking out key tools used to protect the most vulnerable.

“We’re really at a point that may be a crossroads here. As we’re entering into the cooler months, we are starting to see the emergence of sublineage variants of omicron,” Fauci said on the Conversations on Health Care radio show.

Natural infection from the BA.5 subvariant or vaccination with the new boosters should provide protection against these subvariants for healthy people, Fauci said. But U.S. health officials are concerned that the subvariants will basically knock out antibody treatments such as Evusheld that play a key role in protecting people with severely compromised immune systems, he said.

The omicron subvariants BQ.1 and BQ.1.1 are of greatest concern. They are resistant to Evusheld and are increasing in the U.S. every week. BQ.1 and BQ.1.1 represent 27% of infections combined while omicron BA.5 has declined to 50%, according to the Centers for Disease Control and Prevention.

Fauci said the U.S. needs to dramatically reduce the number of Covid deaths, which currently stand at about 400 per day, before the country can declare the pandemic over.

“We’re still in the middle of this — it is not over,” Fauci said. “Four hundred deaths per day is not an acceptable level. We want to get it much lower than that.”

Fauci said hospitals could face a “negative trifecta” this winter from emerging Covid variants as well as resurgent flu and respiratory syncytial virus. The U.S. should expect a more severe flu season based on what scientists observed in Australia, he said. And there’s already a significant uptick in RSV cases in the U.S., he added.

“It’s going to be very confounding and might even stress the hospital system particularly for the pediatric population,” Fauci said.

Though RSV resembles a mild cold for most people, the virus can be dangerous for infants and newborns. Between 58,000 and 80,000 kids younger than 5 are hospitalized with it every year, according to CDC.

CNBC Health & Science

Read CNBC’s latest global health coverage:

The severity of the flu varies season to season depending on the efficacy of the vaccine and the strain circulating. The most severe season of the past decade was in 2017 when the virus killed 52,000 people and hospitalized more than 700,000, according to CDC. In the mildest season pre-pandemic, the flu killed 23,000 people and hospitalized 280,000.

There is no vaccine for RSV yet, though Pfizer has a candidate that was 81% effective at preventing severe disease in newborn infants. New boosters for omicron as well flu shots are widely available.

Fauci said everyone who is eligible should get their Covid boosters and flu shot. People who face a high risk from respiratory viruses should consider wearing a mask indoors in public, Fauci said. Those who have people in their homes who are vulnerable should do the same, he said.

People should also consider taking rapid Covid tests before going to social gatherings indoors where vulnerable individuals will be present, Fauci said.

“That is a very good way of making sure you don’t spread infections, so utilization of tests, wearing masks were appropriate and getting vaccinated,” he said.



Source

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
Health

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly

Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Frontier 2030,” comes as Zealand […]

Read More
Eli Lilly to build  billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs
Health

Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs

Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025. The company announced plans for a $6.5 billion biomanufacturing plant in north Houston. (Raquel Natalicchio/Houston Chronicle via Getty Images) Raquel Natalicchio | Houston Chronicle | Getty Images Eli Lilly on Tuesday said it will spend […]

Read More
A biotech stock for investors scared to invest in the risky industry
Health

A biotech stock for investors scared to invest in the risky industry

Citigroup thinks investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the biotech stock at a buy rating and price target of $270, implying upside of 46% from Ligand’s Monday closing price of $184.67. Shares have soared nearly 79% this year. LGND YTD mountain LGND YTD chart […]

Read More